Investment portfolio.

We provide smart capital for Belgian innovation and driving socio-economic growth.

Our role is to create
sustainable long-term value.
all our investments are driven by our values.

THE FAKTORY FUND
Détention du capital14.99 %
The Faktory II fund aims to provide seed capital to technology (mainly Internet of Things and Software as a Service) companies aiming at global leadership in 2B market niches. Created in December 2019, it invests only in companies that offer a product, not a service, so that it can be deployed globally.
THEODORUS III
Détention du capital24.69 %
A university investment fund.
THEODORUS IV
Détention du capital30.42 %
The Theodorus IV Fund has as its particularity compared to its predecessors the way in which the ULB and the researchers are paid, and in its desire to bring into the capital of investors outside Belgium to enhance the investment policy of Theodorus.
UNID MANUFACTURING
Détention du capital5.93 %
Company that manufactures pharmaceutical products.
UNIFIED POST
Détention du capital2.37 %
The Fintech company Unified Post Group, located in La Hulpe, was founded in 2001 and focuses on optimizing the electronic processing of flow invoices and other professional documents. The company distinguishes itself by acting as a one stop shop for its customers (unique platform) and by providing pre-configurated solutions for each sector.
UNIFLY
Détention du capital3.50 %
Unifly has developed a platform for the exchange of information between drone pilots, authorities and airspace users (below 500 feet).
UNIVERCELLS
Détention du capital4.89 %
Univercells was founded in 2013 in Gosselies to make biologics available and affordable for everyone. As a provider of innovative bioproduction platforms and solutions, it focuses on increasing the availability of affordable biologics.
V-BIO FUND II
Détention du capital13.90 %
Investment fund focussing on finding, creating and financing young and innovative companies with ambitions in life sciences.
V-BIO VENTURES FUND I ARKIV
Détention du capital6.59 %
Investment fund focussing on finding, creating and financing young and innovative companies with ambitions in life sciences.
VESALIUS BIOCAPITAL I
Détention du capital6.67 %
Venture capital fund that invests in life science companies creating innovative cutting-edge technologies.
VESALIUS BIOCAPITAL III
Détention du capital8.92 %
Vesalius Biocapital III was established as a European venture capital fund in the life sciences field. The fund has set itself the goal of building up a balanced portfolio consisting of between 10 and 12 companies that develop new medicines, diagnostics, medical devices and applications for digital healthcare.
VIVES II
Détention du capital11.68 %
Vives II is a multi-sectorial UCL associated investment fund for investment in new high-tech companies which, in particular, produce innovative work in the field of ecology.
VIVES INTER-UNIVERSITY FUND
Détention du capital20.00 %
Launched in the summer of 2020, the Vives Inter-University Fund (Vives III) is a multi-sector technology fund that invests in projects with a positive impact on society. The fund invests in spin-offs from UCLouvain [Catholic University of Louvain] or its universities as well as in start-ups.
VOLTA VENTURES
Détention du capital12.79 %
<p class="p1">Following the example of its predecessor Volta Ventures I, which was launched in 2014, this fund invests in software and internet companies in the Benelux. The Volta Ventures team aims to acquire stakes in around twenty companies over the next five years. It will focus on innovative start-ups with strong and balanced teams, but also on a unique market position and a scalable business model.</p>
WELLINGTON PARTNER LIFE SCIENCES V GmbH (EIF)
Détention du capital0.01 %
Wellington Partners Technology is a leading European venture capital firm specialising in investments in early- and growth-stage technology and life science companies.
WHITE FUND (Medtech)
Détention du capital15.08 %
White fund was created in October 2019 and aspires to become the new reference investment fund in Belgium for early stage medtech companies.
11 | 12
1 2 10 11 12

SFPIM is a stable partner who provides support for innovation and growth to create long-term value for Belgian society.